Details for 2021180378
Up to date per 03.04.2026
Actions
Details for 2021180378
Granted/Registered
European Patent
20.04.2022 A
09.04.2025 B1
10.08.2014
US
201462035485 P
A61M 5/20 20060101AFI20220314BHEP
Owner
Antares Pharma, Inc.100 Princeton South Corporate Center Suite 300 Ewing, New Jersey 08628US
Representative
No representatives present
Inventor
MEHAWEJ, John Pierre Robbinsdale 55422US
TRAVANTY, Michael Minneapolis 55407US
Information about Fees